eCite Digital Repository
Treatment with Etanercept in a Patient with Rheumatoid Arthritis-Associated Interstitial Lung Disease
Citation
Wang, Y and Xu, SQ and Xu, JH and Ding, C, Treatment with Etanercept in a Patient with Rheumatoid Arthritis-Associated Interstitial Lung Disease, Clinical Medicine Insights: Case Reports, 4 pp. 49-52. ISSN 1179-5476 (2011) [Contribution to Refereed Journal]
 | PDF Pending copyright assessment - Request a copy 1Mb |
Abstract
We report a case of a 52-year-old woman with a 1-year history of rheumatoid arthritis-associated interstitial lung disease referred to
hospital because of aggravated pulmonary symptoms in spite of intensive treatment including prednisone, azathioprine and triptergium glycoside.
We subsequently initiated treatment with 25 mg of etanercept, subcutaneously injected twice weekly. Following 6 months of therapy with this agent,
sustained improvement in dyspnea, cough was reported by the patient and respiratory function test showed marked improvement. The improvement
was confirmed by reduced middle and lower lung markings on chest radiography and high-resolution CT scan. This report suggests etanercept may be
effective in the treatment of rheumatoid arthritis-associated interstitial lung disease.
Item Details
| Item Type: | Contribution to Refereed Journal |
|---|---|
| Keywords: | rheumatoid arthritis, interstitial lung disease, etanercept |
| Research Division: | Biomedical and Clinical Sciences |
| Research Group: | Clinical sciences |
| Research Field: | Rheumatology and arthritis |
| Objective Division: | Health |
| Objective Group: | Clinical health |
| Objective Field: | Clinical health not elsewhere classified |
| UTAS Author: | Ding, C (Professor Chang-Hai Ding) |
| ID Code: | 75692 |
| Year Published: | 2011 |
| Deposited By: | Menzies Institute for Medical Research |
| Deposited On: | 2012-02-09 |
| Last Modified: | 2012-06-18 |
| Downloads: | 0 |
Repository Staff Only: item control page